In this study, we demonstrate that anti-CCL2 antibody suppresses in vitro monocyte and neuroblastoma migration to CCL2, and when combined with chemotherapy, improves survival in our tumor resection mouse model of neuroblastoma. The gene discussed is CCL2; the disease is neoplasm.